These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 3494255

  • 1. In morphinised rats SKF 38393 converts dopamine D2 receptor-mediated forward locomotion into backward walking.
    Axon DI, Fletcher GH, Starr MS.
    Pharmacol Biochem Behav; 1987 Jan; 26(1):45-7. PubMed ID: 3494255
    [Abstract] [Full Text] [Related]

  • 2. Behavioural interactions involving D1 and D2 dopamine receptors in non-habituated mice.
    Starr BS, Starr MS.
    Neuropharmacology; 1987 Jun; 26(6):613-9. PubMed ID: 2955244
    [Abstract] [Full Text] [Related]

  • 3. Behavioural role of dopamine D1 receptors in the reserpine-treated mouse.
    Starr BS, Starr MS, Kilpatrick IC.
    Neuroscience; 1987 Jul; 22(1):179-88. PubMed ID: 2957609
    [Abstract] [Full Text] [Related]

  • 4. Role of the substantia nigra in the expression of dopamine D1 receptor-mediated and D2 receptor-mediated behaviours.
    Fletcher GH, Starr MS.
    Neuroscience; 1987 Dec; 23(3):1001-10. PubMed ID: 2963970
    [Abstract] [Full Text] [Related]

  • 5. Topography of dopamine behaviours mediated by D1 and D2 receptors revealed by intrastriatal injection of SKF 38393, lisuride and apomorphine in rats with a unilateral 6-hydroxydopamine-induced lesion.
    Fletcher GH, Starr MS.
    Neuroscience; 1987 Feb; 20(2):589-97. PubMed ID: 2953990
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of dopamine D1 and D2 agonists and antagonists on velocity of movement, rearing and grooming in the mouse. Implications for the roles of D1 and D2 receptors.
    Starr BS, Starr MS.
    Neuropharmacology; 1986 May; 25(5):455-63. PubMed ID: 3488514
    [Abstract] [Full Text] [Related]

  • 7. Grooming in the mouse is stimulated by the dopamine D1 agonist SKF 38393 and by low doses of the D1 antagonist SCH 23390, but is inhibited by dopamine D2 agonists, D2 antagonists and high doses of SCH 23390.
    Starr BS, Starr MS.
    Pharmacol Biochem Behav; 1986 Apr; 24(4):837-9. PubMed ID: 2940604
    [Abstract] [Full Text] [Related]

  • 8. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG, Walters JR.
    Brain Res; 1987 Mar 10; 405(2):234-46. PubMed ID: 2952219
    [Abstract] [Full Text] [Related]

  • 9. Effect of the D1 receptor agonist SKF 38393 on some behavioural effects of apomorphine in rats.
    Zarkovsky AM, Cereska KS.
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Apr 10; 339(4):383-6. PubMed ID: 2567965
    [Abstract] [Full Text] [Related]

  • 10. Sniffing, rearing and locomotor responses to the D-1 dopamine agonist R-SK&F 38393 and to apomorphine: differential interactions with the selective D-1 and D-2 antagonists SCH 23390 and metoclopramide.
    Molloy AG, Waddington JL.
    Eur J Pharmacol; 1985 Feb 05; 108(3):305-8. PubMed ID: 3886407
    [Abstract] [Full Text] [Related]

  • 11. Opposing roles of dopamine D1 and D2 receptors in nigral gamma-[3H]aminobutyric acid release?
    Starr M.
    J Neurochem; 1987 Oct 05; 49(4):1042-9. PubMed ID: 2957468
    [Abstract] [Full Text] [Related]

  • 12. Effects of dopamine D1 and D2 receptor agonists and antagonists on bombesin-induced behaviors.
    Merali Z, Piggins H.
    Eur J Pharmacol; 1990 Dec 04; 191(3):281-93. PubMed ID: 2086245
    [Abstract] [Full Text] [Related]

  • 13. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan 04; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 14. Locomotor behaviors in response to new selective D-1 and D-2 dopamine receptor agonists, and the influence of selective antagonists.
    Molloy AG, O'Boyle KM, Pugh MT, Waddington JL.
    Pharmacol Biochem Behav; 1986 Jul 04; 25(1):249-53. PubMed ID: 3529126
    [Abstract] [Full Text] [Related]

  • 15. Dopamine D2 synthesis-modulating receptors are present in the striatum of the guinea pig.
    Johnson EA, Tsai CE, Lucci J, Harrison-Shahan Y, Azzaro AJ.
    Neuropharmacology; 1992 Jan 04; 31(1):95-101. PubMed ID: 1347405
    [Abstract] [Full Text] [Related]

  • 16. Enhancement by the D1 dopamine agonist SKF 38393 of specific components of stereotypy elicited by the D2 agonists LY 171555 and RU 24213.
    Meller E, Bordi F, Bohmaker K.
    Life Sci; 1988 Jan 04; 42(25):2561-7. PubMed ID: 3260320
    [Abstract] [Full Text] [Related]

  • 17. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats.
    Monti JM, Fernández M, Jantos H.
    Neuropsychopharmacology; 1990 Jun 04; 3(3):153-62. PubMed ID: 2141985
    [Abstract] [Full Text] [Related]

  • 18. Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors?
    White FJ, Bednarz LM, Wachtel SR, Hjorth S, Brooderson RJ.
    Pharmacol Biochem Behav; 1988 May 04; 30(1):189-93. PubMed ID: 2902644
    [Abstract] [Full Text] [Related]

  • 19. Opposite effects of stimulation of D1 and D2 dopamine receptors on the expression of motor seizures in mouse and rat.
    al-Tajir G, Chandler CJ, Starr BS, Starr MS.
    Neuropharmacology; 1990 Jul 04; 29(7):657-61. PubMed ID: 1974713
    [Abstract] [Full Text] [Related]

  • 20. Dopamine receptor subtypes and formalin test analgesia.
    Morgan MJ, Franklin KB.
    Pharmacol Biochem Behav; 1991 Oct 04; 40(2):317-22. PubMed ID: 1687167
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.